FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury

Summary: Idiopathic pulmonary fibrosis is a common form of interstitial lung disease resulting in alveolar remodeling and progressive loss of pulmonary function because of chronic alveolar injury and failure to regenerate the respiratory epithelium. Histologically, fibrotic lesions and honeycomb str...

Full description

Bibliographic Details
Main Authors: Tingting Yuan, Thomas Volckaert, Elizabeth F. Redente, Seantel Hopkins, Kylie Klinkhammer, Roxana Wasnick, Cho-Ming Chao, Jie Yuan, Jin-San Zhang, Changfu Yao, Susan Majka, Barry R. Stripp, Andreas Günther, David W.H. Riches, Saverio Bellusci, Victor J. Thannickal, Stijn P. De Langhe
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671119301250
id doaj-fcba214ffea4484dac67b28149cb14a9
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Tingting Yuan
Thomas Volckaert
Elizabeth F. Redente
Seantel Hopkins
Kylie Klinkhammer
Roxana Wasnick
Cho-Ming Chao
Jie Yuan
Jin-San Zhang
Changfu Yao
Susan Majka
Barry R. Stripp
Andreas Günther
David W.H. Riches
Saverio Bellusci
Victor J. Thannickal
Stijn P. De Langhe
spellingShingle Tingting Yuan
Thomas Volckaert
Elizabeth F. Redente
Seantel Hopkins
Kylie Klinkhammer
Roxana Wasnick
Cho-Ming Chao
Jie Yuan
Jin-San Zhang
Changfu Yao
Susan Majka
Barry R. Stripp
Andreas Günther
David W.H. Riches
Saverio Bellusci
Victor J. Thannickal
Stijn P. De Langhe
FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
Stem Cell Reports
author_facet Tingting Yuan
Thomas Volckaert
Elizabeth F. Redente
Seantel Hopkins
Kylie Klinkhammer
Roxana Wasnick
Cho-Ming Chao
Jie Yuan
Jin-San Zhang
Changfu Yao
Susan Majka
Barry R. Stripp
Andreas Günther
David W.H. Riches
Saverio Bellusci
Victor J. Thannickal
Stijn P. De Langhe
author_sort Tingting Yuan
title FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
title_short FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
title_full FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
title_fullStr FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
title_full_unstemmed FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
title_sort fgf10-fgfr2b signaling generates basal cells and drives alveolar epithelial regeneration by bronchial epithelial stem cells after lung injury
publisher Elsevier
series Stem Cell Reports
issn 2213-6711
publishDate 2019-05-01
description Summary: Idiopathic pulmonary fibrosis is a common form of interstitial lung disease resulting in alveolar remodeling and progressive loss of pulmonary function because of chronic alveolar injury and failure to regenerate the respiratory epithelium. Histologically, fibrotic lesions and honeycomb structures expressing atypical proximal airway epithelial markers replace alveolar structures, the latter normally lined by alveolar type 1 (AT1) and AT2 cells. Bronchial epithelial stem cells (BESCs) can give rise to AT2 and AT1 cells or honeycomb cysts following bleomycin-mediated lung injury. However, little is known about what controls this binary decision or whether this decision can be reversed. Here we report that inactivation of Fgfr2b in BESCs impairs their contribution to both alveolar epithelial regeneration and honeycomb cysts after bleomycin injury. By contrast overexpression of Fgf10 in BESCs enhances fibrosis resolution by favoring the more desirable outcome of alveolar epithelial regeneration over the development of pathologic honeycomb cysts. : FGF10-FGFR2B signaling in bronchial epithelial stem cells is critical to drive both alveolar epithelial regeneration and the development of honeycomb cysts after bleomycin injury. Overexpression of Fgf10 in bronchial epithelial stem cells enhances fibrosis resolution by favoring the more desirable outcome of alveolar epithelial regeneration over the development of pathologic honeycomb cysts. Keywords: lung stem cells, lung regeneration, lung fibrosis, Fgf signaling
url http://www.sciencedirect.com/science/article/pii/S2213671119301250
work_keys_str_mv AT tingtingyuan fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT thomasvolckaert fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT elizabethfredente fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT seantelhopkins fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT kylieklinkhammer fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT roxanawasnick fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT chomingchao fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT jieyuan fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT jinsanzhang fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT changfuyao fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT susanmajka fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT barryrstripp fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT andreasgunther fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT davidwhriches fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT saveriobellusci fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT victorjthannickal fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
AT stijnpdelanghe fgf10fgfr2bsignalinggeneratesbasalcellsanddrivesalveolarepithelialregenerationbybronchialepithelialstemcellsafterlunginjury
_version_ 1725144241435312128
spelling doaj-fcba214ffea4484dac67b28149cb14a92020-11-25T01:18:01ZengElsevierStem Cell Reports2213-67112019-05-0112510411055FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung InjuryTingting Yuan0Thomas Volckaert1Elizabeth F. Redente2Seantel Hopkins3Kylie Klinkhammer4Roxana Wasnick5Cho-Ming Chao6Jie Yuan7Jin-San Zhang8Changfu Yao9Susan Majka10Barry R. Stripp11Andreas Günther12David W.H. Riches13Saverio Bellusci14Victor J. Thannickal15Stijn P. De Langhe16Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USADepartment of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USADepartment of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO 80206, USA; Denver Veteran Affairs Medical Center, Denver, CO 80206, USADepartment of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USADepartment of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USAGerman Center for Lung Research, Excellence Cluster Cardio-Pulmonary System, Universities of Giessen and Marburg Lung Center, 35392 Giessen, GermanyGerman Center for Lung Research, Excellence Cluster Cardio-Pulmonary System, Universities of Giessen and Marburg Lung Center, 35392 Giessen, GermanyDepartment of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USASchool of Pharmaceutical Sciences, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaWomen's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USADepartment of Medicine, National Jewish Health, Denver, CO 80206, USAWomen's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USAGerman Center for Lung Research, Excellence Cluster Cardio-Pulmonary System, Universities of Giessen and Marburg Lung Center, 35392 Giessen, GermanyDepartment of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO 80206, USA; Denver Veteran Affairs Medical Center, Denver, CO 80206, USAGerman Center for Lung Research, Excellence Cluster Cardio-Pulmonary System, Universities of Giessen and Marburg Lung Center, 35392 Giessen, GermanyDepartment of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USADepartment of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue S., Birmingham, 35294-2182 AL, USA; Corresponding authorSummary: Idiopathic pulmonary fibrosis is a common form of interstitial lung disease resulting in alveolar remodeling and progressive loss of pulmonary function because of chronic alveolar injury and failure to regenerate the respiratory epithelium. Histologically, fibrotic lesions and honeycomb structures expressing atypical proximal airway epithelial markers replace alveolar structures, the latter normally lined by alveolar type 1 (AT1) and AT2 cells. Bronchial epithelial stem cells (BESCs) can give rise to AT2 and AT1 cells or honeycomb cysts following bleomycin-mediated lung injury. However, little is known about what controls this binary decision or whether this decision can be reversed. Here we report that inactivation of Fgfr2b in BESCs impairs their contribution to both alveolar epithelial regeneration and honeycomb cysts after bleomycin injury. By contrast overexpression of Fgf10 in BESCs enhances fibrosis resolution by favoring the more desirable outcome of alveolar epithelial regeneration over the development of pathologic honeycomb cysts. : FGF10-FGFR2B signaling in bronchial epithelial stem cells is critical to drive both alveolar epithelial regeneration and the development of honeycomb cysts after bleomycin injury. Overexpression of Fgf10 in bronchial epithelial stem cells enhances fibrosis resolution by favoring the more desirable outcome of alveolar epithelial regeneration over the development of pathologic honeycomb cysts. Keywords: lung stem cells, lung regeneration, lung fibrosis, Fgf signalinghttp://www.sciencedirect.com/science/article/pii/S2213671119301250